scholarly journals Corrigendum: Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism

2019 ◽  
Vol 10 ◽  
Author(s):  
Souraya Sayegh ◽  
Oula El Atat ◽  
Katy Diallo ◽  
Benjamin Rauwel ◽  
Yannick Degboé ◽  
...  
2021 ◽  
pp. 101709
Author(s):  
Sheida Farrokhi ◽  
Fattah sotoodehnejadnematalahi ◽  
Anwar Fathollahi ◽  
Mostafa Haji Molla Hoseini ◽  
Seyed Mahmoud Hashemi ◽  
...  

2010 ◽  
Vol 135 (3) ◽  
pp. 448-458 ◽  
Author(s):  
Ke Chen ◽  
Ding Wang ◽  
Wei Ting Du ◽  
Zhi-Bo Han ◽  
He Ren ◽  
...  

Stem Cells ◽  
2012 ◽  
Vol 30 (5) ◽  
pp. 975-987 ◽  
Author(s):  
Siddaraju V. Boregowda ◽  
Veena Krishnappa ◽  
Jeremy W. Chambers ◽  
Philip V. Lograsso ◽  
Wen-Tzu Lai ◽  
...  

Author(s):  
Marlena Tynecka ◽  
Marcin Moniuszko ◽  
Andrzej Eljaszewicz

AbstractMesenchymal stem cells (MSCs) have a great regenerative and immunomodulatory potential that was successfully tested in numerous pre-clinical and clinical studies of various degenerative, hematological and inflammatory disorders. Over the last few decades, substantial immunoregulatory effects of MSC treatment were widely observed in different experimental models of asthma. Therefore, it is tempting to speculate that stem cell-based treatment could become an attractive means to better suppress asthmatic airway inflammation, especially in subjects resistant to currently available anti-inflammatory therapies. In this review, we discuss mechanisms accounting for potent immunosuppressive properties of MSCs and the rationale for their use in asthma. We describe in detail an intriguing interplay between MSCs and other crucial players in the immune system as well as lung microenvironment. Finally, we reveal the potential of MSCs in maintaining airway epithelial integrity and alleviating lung remodeling. Graphical abstract


Sign in / Sign up

Export Citation Format

Share Document